CD274 and head and neck squamous cell carcinoma: Importantly, emerging evidence suggests that the immune checkpoint molecule programmed cell death ligand 1 (PD-L1) is expressed by CSCs from glioblastoma (38), HNSCC (39), breast, and colon cancer (40, 41).